Chanoch Miodownik

Summary

Publications

  1. ncbi request reprint The effect of sudden clozapine discontinuation on management of schizophrenic patients: A retrospective controlled study
    Chanoch Miodownik
    Division of Psychiatry, Ben Gurion University of the Negev, Beer Sheva, Israel
    J Clin Psychiatry 67:1204-8. 2006
  2. ncbi request reprint Quetiapine: efficacy, tolerability and safety in schizophrenia
    Chanoch Miodownik
    University of the Negev, Division of Psychiatry, Faculty of Health Sciences Ben Gurion, Be er Sheva, Israel
    Expert Rev Neurother 6:983-92. 2006
  3. ncbi request reprint Vitamin B6 treatment for tardive dyskinesia: a randomized, double-blind, placebo-controlled, crossover study
    Vladimir Lerner
    Division of Psychiatry, Ministry of Health Be er Sheva Mental Health Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Be er Sheva, Israel
    J Clin Psychiatry 68:1648-54. 2007
  4. ncbi request reprint Vitamin B6 versus mianserin and placebo in acute neuroleptic-induced akathisia: a randomized, double-blind, controlled study
    Chanoch Miodownik
    Mental Health Center, Faculty of Health Sciences Ben Gurion University of the Negev, Be er Sheva, Israel
    Clin Neuropharmacol 29:68-72. 2006
  5. ncbi request reprint The retinoid X receptor agonist bexarotene relieves positive symptoms of schizophrenia: a 6-week, randomized, double-blind, placebo-controlled multicenter trial
    Vladimir Lerner
    Division of Psychiatry, Ministry of Health Mental Health Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Be er Sheva
    J Clin Psychiatry 74:1224-32. 2013
  6. ncbi request reprint The prevalence of neuroleptic drug-induced tardive movement subsyndromes among schizophrenic and schizoaffective patients residing in the southern region of Israel
    Vladimir Lerner
    Division of Psychiatry, Ministry of Health Mental Health Center, and Faculty of Health Sciences, Ben Gurion University of the Negev, Beersheba, Israel
    Isr J Psychiatry Relat Sci 44:20-8. 2007
  7. ncbi request reprint High-dose vitamin B6 decreases homocysteine serum levels in patients with schizophrenia and schizoaffective disorders: a preliminary study
    Chanoch Miodownik
    Division of Psychiatry, Ministry of Health, Mental Health Center, Faculty of Health Sciences Ben Gurion University of the Negev, Be er Sheva, Israel
    Clin Neuropharmacol 30:13-7. 2007
  8. ncbi request reprint Vitamin B6 treatment in acute neuroleptic-induced akathisia: a randomized, double-blind, placebo-controlled study
    Vladimir Lerner
    Mental Health Center, Faculty of Health Sciences Ben Gurion University of the Negev, Be er Sheva, Israel
    J Clin Psychiatry 65:1550-4. 2004
  9. ncbi request reprint [Vitamin B6 add-on therapy in treatment of schizophrenic patients with psychotic symptoms and movement disorders]
    Chanoch Miodownik
    Ministry of Health, Mental Health Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheba, Israel
    Harefuah 142:592-6, 647. 2003
  10. doi request reprint Pyridoxal plasma level in schizophrenic and schizoaffective patients with and without tardive dyskinesia
    Chanoch Miodownik
    Division of Psychiatry, Ministry of Health Be er Sheva Mental Health Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Be er Sheva, Israel
    Clin Neuropharmacol 31:197-203. 2008

Detail Information

Publications24

  1. ncbi request reprint The effect of sudden clozapine discontinuation on management of schizophrenic patients: A retrospective controlled study
    Chanoch Miodownik
    Division of Psychiatry, Ben Gurion University of the Negev, Beer Sheva, Israel
    J Clin Psychiatry 67:1204-8. 2006
    ....
  2. ncbi request reprint Quetiapine: efficacy, tolerability and safety in schizophrenia
    Chanoch Miodownik
    University of the Negev, Division of Psychiatry, Faculty of Health Sciences Ben Gurion, Be er Sheva, Israel
    Expert Rev Neurother 6:983-92. 2006
    ..There are also continued efforts to understand, predict and manage the side-effect risk with quetiapine...
  3. ncbi request reprint Vitamin B6 treatment for tardive dyskinesia: a randomized, double-blind, placebo-controlled, crossover study
    Vladimir Lerner
    Division of Psychiatry, Ministry of Health Be er Sheva Mental Health Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Be er Sheva, Israel
    J Clin Psychiatry 68:1648-54. 2007
    ..The aims of this study were (1) to reexamine the efficacy and safety of higher doses of vitamin B(6) versus placebo in a greater sample of patients for a longer time and (2) to evaluate the carryover effect of vitamin B(6)...
  4. ncbi request reprint Vitamin B6 versus mianserin and placebo in acute neuroleptic-induced akathisia: a randomized, double-blind, controlled study
    Chanoch Miodownik
    Mental Health Center, Faculty of Health Sciences Ben Gurion University of the Negev, Be er Sheva, Israel
    Clin Neuropharmacol 29:68-72. 2006
    ..The efficacy of vitamin B(6) and mianserin suggests that the pathophysiology of acute NIA is heterogeneous with the various subtypes of acute NIA responding differently to the various pharmacological approaches...
  5. ncbi request reprint The retinoid X receptor agonist bexarotene relieves positive symptoms of schizophrenia: a 6-week, randomized, double-blind, placebo-controlled multicenter trial
    Vladimir Lerner
    Division of Psychiatry, Ministry of Health Mental Health Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Be er Sheva
    J Clin Psychiatry 74:1224-32. 2013
    ..This trial aimed to investigate efficacy and safety of add-on bexarotene to ongoing antipsychotic treatment of patients with schizophrenia or schizoaffective disorder...
  6. ncbi request reprint The prevalence of neuroleptic drug-induced tardive movement subsyndromes among schizophrenic and schizoaffective patients residing in the southern region of Israel
    Vladimir Lerner
    Division of Psychiatry, Ministry of Health Mental Health Center, and Faculty of Health Sciences, Ben Gurion University of the Negev, Beersheba, Israel
    Isr J Psychiatry Relat Sci 44:20-8. 2007
    ..35%; P<0.02). TMD generally appears in a combined fashion. Further prospective studies from different geographical areas are recommended...
  7. ncbi request reprint High-dose vitamin B6 decreases homocysteine serum levels in patients with schizophrenia and schizoaffective disorders: a preliminary study
    Chanoch Miodownik
    Division of Psychiatry, Ministry of Health, Mental Health Center, Faculty of Health Sciences Ben Gurion University of the Negev, Be er Sheva, Israel
    Clin Neuropharmacol 30:13-7. 2007
    ....
  8. ncbi request reprint Vitamin B6 treatment in acute neuroleptic-induced akathisia: a randomized, double-blind, placebo-controlled study
    Vladimir Lerner
    Mental Health Center, Faculty of Health Sciences Ben Gurion University of the Negev, Be er Sheva, Israel
    J Clin Psychiatry 65:1550-4. 2004
    ..The purpose of this study was to evaluate the efficacy of vitamin B6 in the treatment of acute NIA. This is the first report of B6 as a treatment for NIA...
  9. ncbi request reprint [Vitamin B6 add-on therapy in treatment of schizophrenic patients with psychotic symptoms and movement disorders]
    Chanoch Miodownik
    Ministry of Health, Mental Health Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheba, Israel
    Harefuah 142:592-6, 647. 2003
    ..In this study vitamin B6 treatment was provided to 15 patients who suffered from schizophrenia and schizoaffective disorder with positive psychotic symptoms and tardive dyskinesia...
  10. doi request reprint Pyridoxal plasma level in schizophrenic and schizoaffective patients with and without tardive dyskinesia
    Chanoch Miodownik
    Division of Psychiatry, Ministry of Health Be er Sheva Mental Health Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Be er Sheva, Israel
    Clin Neuropharmacol 31:197-203. 2008
    ..The aim of this study was to compare plasma pyridoxal-5-phosphate (PLP) levels in schizophrenic patients with and without TD...
  11. doi request reprint Delirium associated with lithium-quetiapine combination
    Chanoch Miodownik
    Division of Psychiatry, Ministry of Health Mental Health Center, Faculty of Health Sciences Ben Gurion University of the Negev, Be er Sheva, Israel
    Clin Neuropharmacol 31:176-9. 2008
    ..There are only few reports about it within therapeutic serum levels. The question of toxic interactions resulting from combinations of lithium and neuroleptic drugs is largely based on anecdotal reports...
  12. ncbi request reprint Pisa syndrome and laryngeal dystonia induced by novel antipsychotics
    Chanoch Miodownik
    Division of Psychiatry, Ministry of Health, Mental Health Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel
    Isr J Psychiatry Relat Sci 48:195-200. 2011
    ..Publications about tardive movement disturbances induced by these medications become more and more frequent. Our report does not address the management of the patients tardive dystonia but only illustrates the phenomenon...
  13. ncbi request reprint Augmentation with amisulpride for schizophrenic patients nonresponsive to antipsychotic monotherapy
    Vladimir Lerner
    Ministry of Health Mental Health Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Be er Sheva, Israel
    Clin Neuropharmacol 28:66-71. 2005
    ..The results are preliminary and require confirmation in a randomized controlled trial. The authors suggest that amisulpride may be a promising option as an augmentation strategy in treatment-resistant schizophrenic patients...
  14. doi request reprint Serum levels of brain-derived neurotrophic factor and cortisol to sulfate of dehydroepiandrosterone molar ratio associated with clinical response to L-theanine as augmentation of antipsychotic therapy in schizophrenia and schizoaffective disorder patients
    Chanoch Miodownik
    Division of Psychiatry, Faculty of Health Sciences Ben Gurion University of the Negev, Ministry of Health Be er Sheva Mental Health Center, Be er Sheva, Israel
    Clin Neuropharmacol 34:155-60. 2011
    ..This study examines the association between circulating levels of neurochemical indicators and the beneficial clinical effects of L-theanine augmentation...
  15. ncbi request reprint Efficacy of piracetam in the treatment of tardive dyskinesia in schizophrenic patients: a randomized, double-blind, placebo-controlled crossover study
    Igor Libov
    Division of Psychiatry, Ministry of Health, Be er Sheva Mental Health Center and the Faculty of Health Sciences, Ben Gurion University of the Negev, Be er Sheva, Israel
    J Clin Psychiatry 68:1031-7. 2007
    ..The aim of our study was to reexamine the efficacy of piracetam in the treatment of tardive dyskinesia using an oral preparation...
  16. doi request reprint Motor symptoms of schizophrenia: is tardive dyskinesia a symptom or side effect? A modern treatment
    Vladimir Lerner
    Be er Sheva Mental Health Center, Ben Gurion University of the Negev, P O Box 4600, Be er Sheva, 84170, Israel
    Curr Psychiatry Rep 13:295-304. 2011
    ..Moreover, there is solid evidence of a genetic predisposition to TD. This article summarizes recent relevant publications concerning TD and the most recent studies regarding treatment of this disorder with antioxidative agents...
  17. ncbi request reprint Vitamin B6 as add-on treatment in chronic schizophrenic and schizoaffective patients: a double-blind, placebo-controlled study
    Vladimir Lerner
    Ministry of Health Mental Health Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Be er Sheva, Israel
    J Clin Psychiatry 63:54-8. 2002
    ..The aim of this study was to examine whether vitamin B6 therapy influences psychotic symptoms in patients suffering from schizophrenia and schizoaffective disorder...
  18. ncbi request reprint High serum homocysteine levels in young male schizophrenic and schizoaffective patients with tardive parkinsonism and/or tardive dyskinesia
    Vladimir Lerner
    Division of Psychiatry, Ministry of Health Mental Health Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Be er Sheva, 84170 Israel
    J Clin Psychiatry 66:1558-63. 2005
    ..The aim of our study was to determine whether there is an association between serum total homocysteine level and the presence of TMD among schizophrenic and schizoaffective patients...
  19. ncbi request reprint Lithium intoxication associated with intramuscular ziprasidone in schizoaffective patients
    Chanoch Miodownik
    Division of Psychiatry, Ministry of Health Mental Health Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Be er Sheva, 84170 Israel
    Clin Neuropharmacol 28:295-7. 2005
    ....
  20. doi request reprint Bexarotene as add-on to antipsychotic treatment in schizophrenia patients: a pilot open-label trial
    Vladimir Lerner
    Division of Psychiatry, Ministry of Health Mental Health Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Be er Sheva, Israel
    Clin Neuropharmacol 31:25-33. 2008
    ..This study is the first to investigate the safety and efficacy of add-on oral bexarotene to ongoing antipsychotic treatment in chronic schizophrenia patients who were stabilized on regular antipsychotic treatment...
  21. doi request reprint Curcumin as an add-on to antidepressive treatment: a randomized, double-blind, placebo-controlled, pilot clinical study
    Joseph Bergman
    Mental Health Center Tirat Carmel, Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
    Clin Neuropharmacol 36:73-7. 2013
    ..We sought to evaluate the efficacy of curcumin as an antidepressive agent in a combination with other antidepressants in patients with major depression...
  22. ncbi request reprint Lithium-induced tremor treated with vitamin B6: a preliminary case series
    Chanoch Miodownik
    Be er Sheva Mental Health Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Israel
    Int J Psychiatry Med 32:103-8. 2002
    ..Vitamin B6 has been reported to be effective in treatment of patients suffering from different kinds of neuroleptic-induced movement disorders including parkinsonism and tardive dyskinesia...
  23. ncbi request reprint Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder
    Joseph Zohar
    Division of Psychiatry, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel
    J Clin Psychopharmacol 22:190-5. 2002
    ..Adequately powered studies are needed to confirm these results and to assess whether continued treatment maintains or further improves response...
  24. ncbi request reprint Vitamin B12 and folate serum levels in newly admitted psychiatric patients
    Vladimir Lerner
    Division of Psychiatry, Ministry of Health Mental Health Center, Faculty of Health Sciences Ben Gurion University of the Negev, Be er Sheva, Israel
    Clin Nutr 25:60-7. 2006
    ..We compared cobalamin and folate levels in newly admitted psychiatric patients to mentally healthy controls and assessed their correlation with various psychiatric conditions...